Objectives of Drug Delivery
Objectives of Drug Delivery
Sustained Release
• The conventional dosage forms
• Dosage form �Absorption pool� Target pool�
• The rate of absorption is rate limiting step
• Sustained Release
• Dosage form � Target pool�
• The release of the drug from the dosage from is rate
limiting step.
Application
Classification
• No immediate –release delivery
systems may classified as follows:-
• Delayed release
• Sustained release
• Controlled
• Prolonged
• Site specific release
• Receptor release
• Delayed release:- system uses repetitive
intermitted dosing of a drug from one or more
immediate release units incorporated in a single
dosage form.
• Sustained Release:- includes any drug delivery
system that
achieves slow release of drug over and extended
period of
time.
• Site specific:- targeting the drug effectively to
a certain
biological location.
Potential advantages of
sustained release
• Avoid patient compliance problem
• Employ less total drug
• Minimizing or eliminate local side effects.
• Minimizing or eliminate systemic side effects.
• Minimize drug accumulation.
• Improve the efficiency of the treatment
• Cure or control condition more promptly
• Reduce the fluctuation in drug level.
• Improves bioavailability
• Economy
Controlled Release:
Art or Science?
Adjusting the Drug Flux Through Polymers
• Change of the Polymer Structure (Crosslinking, Crystallinity)
• Change Of Thickness (Multilaminate Systems)
• Change Of Barriers (Porosity)
• Change Of Solubility (Plasticizers)
Adjusting the Drug Flux
Through Polymers
• Change of the Polymer Structure (Crosslinking, Crystallinity)
• Change Of Thickness (Multilaminate Systems)
• Change Of Barriers (Porosity)
• Change Of Solubility (Plasticizers)
Osmotic Pump Systems
� Advantages
� Release Rates are Independent of Agent
Properties
� Can Deliver Macromolecules and Ionic Species
� Relatively High Fluxes
� Release Rates are not Dependent on
Environmental Conditions
Cancer
• In 2000, 1.4 million cases of
cancer
• 560,000 deaths, > 1,500 people
a day
• 1/4 of deaths in US are from
cancer
• Cancer cost:
• $37 billion direct medical costs
• $11 billion low productivity